SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC14D9C - Written communication relating to third party tender offer:
SEC Accession No. 0001193125-22-256740
Filing Date
2022-10-03
Accepted
2022-10-03 16:57:15
Documents
7

Document Format Files

Seq Description Document Type Size
1 SC14D9C d257083dsc14d9c.htm SC14D9C 17974
2 EX-99.1 d257083dex991.htm EX-99.1 12418
3 EX-99.2 d257083dex992.htm EX-99.2 33231
4 EX-99.3 d257083dex993.htm EX-99.3 7985
5 EX-99.4 d257083dex994.htm EX-99.4 10406
6 EX-99.5 d257083dex995.htm EX-99.5 984
7 EX-99.6 d257083dex996.htm EX-99.6 858
  Complete submission text file 0001193125-22-256740.txt   85471
Mailing Address 65 HAYDEN AVE 2ND FLOOR LEXINGTON MA 02421
Business Address 65 HAYDEN AVE 2ND FLOOR LEXINGTON MA 02421 617-245-0399
LogicBio Therapeutics, Inc. (Filed by) CIK: 0001664106 (see all company filings)

IRS No.: 471514975 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC14D9C
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 65 HAYDEN AVE 2ND FLOOR LEXINGTON MA 02421
Business Address 65 HAYDEN AVE 2ND FLOOR LEXINGTON MA 02421 617-245-0399
LogicBio Therapeutics, Inc. (Subject) CIK: 0001664106 (see all company filings)

IRS No.: 471514975 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC14D9C | Act: 34 | File No.: 005-90696 | Film No.: 221288211
SIC: 2836 Biological Products, (No Diagnostic Substances)